Navigation Links
Normal Cells May Predict Cancer Virulence
Date:8/28/2008

Finding suggests that treatment that only aims at malignant cells might fall short

THURSDAY, Aug. 28 (HealthDay News) -- Characteristics of normal cells which are present long before any tumor appears may determine how virulent a particular cancer is going to be, new research suggests.

Such cells may travel early on to distant sites in the body, residing innocently there until certain cancer genes are turned on.

"It's definitely conceptually very profound," said Dr. Katrina Podsypanina, a senior research scientist at Memorial-Sloan Kettering Cancer Center in New York City. "Our data seems to point toward the inherent decision that is made when the tumor is formed whether it is highly malignant or not. Moreover, since the characteristic might be dependent on the normal cell status, one might imagine that they might be different between individuals."

The study's senior author is Harold Varmus, who won the 1989 Nobel Prize for his work in cancer genetics and later went on to become director of the National Institutes of Health.

The finding implies that treatments that only target malignant cells may not be effective.

So far, however, the findings have only been shown in mice, and the research involved certain processes that were imposed which wouldn't normally occur in the human body.

"This does suggest that cells can sit for a long time, then be activated," said Dr. Claudine Isaacs, director of the clinical breast cancer program at Georgetown's Lombardi Comprehensive Cancer Center in Washington, D.C. "But these cells were injected into the circulation. Normal breast cells are not supposed to be in the circulation."

Also, the normal cells didn't form tumors until activated.

Conventional medical wisdom holds that the spread of a cancer occurs relatively late in the life of a cancer, happening only after cells from the primary tumor have undergone enough mutations to s
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Clinical depression linked to abnormal emotional brain circuits
2. Brain imaging reveals breakdown of normal emotional processing
3. Normal role for schizophrenia risk gene identified
4. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
5. How Candida albicans transforms from its normally benign form into life-threatening form
6. Grant Supports Study of Abnormal Ring-Shaped Chromosomes
7. How shyness and other normal human traits became sickness
8. Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not
9. Normal tissue not spared in new forms of breast cancer radiotherapy
10. Abnormal immune cells may cause unprovoked anaphylaxis
11. Abnormal glutamine repeats interfere with key transcription factor, leading to neurodegeneration
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Normal Cells May Predict Cancer Virulence
Normal Cells May Predict Cancer Virulence
(Date:1/9/2009)...Inc., Horsham, PA announced that a new Hydrophili...ed to the company,s website that provides a forum ...an go to find the latest developments in device co...d coatings news. , Horsha...rsham, PA announced that a new Hydrophilic Coatin...
(Date:1/9/2009)...nd Peptide, a Massachusetts-based designer and pro... for drug and vaccine discovery organizations worl...mical solutions in the face of the global shortage...trategic usage of new solutions are two leading pe...dges. , Gardner, MA (PRWE...
(Date:1/9/2009)...re/ -- , - New Online Service Provides the ...s at Whatever Age , A new website has been ...esigned specifically to get rid of all examination...AID and it can be found at, http://www.befreefrom...struction, there and then, on how to get rid of ex...
(Date:1/8/2009)...stCall/ - Med-Emerg International Inc. (OTCBB:MDER...of health services, is pleased to announce that it...sly announced plan of arrangement (the "Arrangemen...l meeting of MedEmerg,s shareholders held in Toron...e meeting were in favour of the Arrangement. , Th...
Breaking Medicine News(10 mins):Health News:Blog Launched to Discuss Developments in Hydrophilic Coatings for Medical Devices 2Health News:New Experts Help New England Peptide Combat Global Acetonitrile Shortage; Company Integrating Cost-Effective Chemical Solvent Alternatives 2Health News:New Experts Help New England Peptide Combat Global Acetonitrile Shortage; Company Integrating Cost-Effective Chemical Solvent Alternatives 3Health News:Be Free From Exam Nerves 2Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2
...n scientist at the US Department of Energys Oak Na...to determine to what extent there is a connection ...odel allows climatologists to relate extremes of a...year rainfall at two locations or two time periods...
...new study by researchers in National Institutes of...cal signs of dementia increases with the number of.... Among their findings is the observation that th... cerebral infarcts (strokes) is the most common mi...
14th of June is celebrated universally as the World Blood Donor Day was initiated,
...aimed that cod liver oil might help keep depressio...d University Hospital in Bergen, Norway has come ...cod liver oil, omega-3 fatty acids. The research w...habits and health of about 22,000 subjects aged 40...
Other Medicine News:Health News:Indo-American Develops Model Linking Human Activity to Climate Change 2Health News:Mix of Disease Process in Brain Leads to Dementia 2Health News:World Blood Donor Day 2
(Date:1/8/2009)... LEUVEN, Belgium, January 9 /PRNewswire-FirstCall/...tudied in the Treatment of,Vitreomacular Adhesion...uronext Brussels: THR), a biotechnology company,f...ascular disease and,cancer, announces today that ...microplasmin for the non-surgical treatment of bac...
(Date:1/8/2009)...ney transplantation to be Quark,s second indicatio...iRNA product candidate , , FREMONT, Calif., Ja...a development-stage pharmaceutical company discove...based therapeutics, today announced that it has in...trial evaluating its systemically administered siR...
(Date:1/8/2009)...Southwestern to Identify and Validate Novel Gene E...h Innovative Gene Expression Platform , , FREMO...Gen Biosystems, Inc. (OTC Bulletin Board: WGBS), a...sion, genotyping, cell biology and stem cell resea...arch collaboration with the University of Texas S...
(Date:1/8/2009)... CHICAGO, Jan. 8 If you are taking...y, you,re not alone. Half of the people taking,pr...he reasons are,varied -- they forget, are busy wi... not to. Noncompliance has been called the Achille...neral Everett Koop commented, "Drugs don,t,work i...
Breaking Medicine Technology:ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 2ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 3ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 4Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Good Medicine: Smarter Smartphones for People With Chronic Disease 2Neanderthal bearing teeth 7498 1Neanderthal bearing teeth 7498 2Winter Brings Pet Hazards 7495 1Winter Brings Pet Hazards 7495 2Christopher Reeve Honored as Heroes Hero By CNN 7491 1Christopher Reeve Honored as Heroes Hero By CNN 7491 2Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 1Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 2Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 3Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 4
...-Mar 26, 2007 - A study comparing,the formulations...YD) used in V-HeFT I and V-HeFT II, and BiDil, the...frican American Heart Failure,Trial (A-HeFT) demon...he formulations used may explain why V-HeFT I and ...ing mortality. Using,identical amounts of active d...
...2007 /PRNewswire/ -- DiObex,Inc., a privately- he...pment of therapeutics to treat metabolic diseases,...- 902, a novel Cortisol,Synthesis Inhibitor. , In ...cebo-controlled trial, patients with type 2 diabet...ty, pharmacokinetics and,activity of three dose le...
Other Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 2Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 3
...-ms bursts of 50 Hz separated by .75 s. , Twitch: ... 100 Hz (100 pulses/s) , Train-Of-Four: Single (4...0 mA , Stimulus Pulse: Square Wave Monophasic pul...reen) indicates that the units on; it flashes when...
Anesthesia Associates Nerve Stimulator Model AA 1050
...ral nerve stimulator from B. Braun Medical. It is ...viding advanced digital technology. , ,Your abili...the localization of practically all mixed nerves f...tional optional component for the HNS11 is a steam...
Based on the original MS-III design the new MS-IV includes electrosurgery certification, enhanced keypad and battery compartment designs., ,The MiniStim® MS-IV peripheral nerve stimulator can
Medicine Products: